2024-12-31
Recently, the series of academic training events organized by Tianjiang Pharmaceutical and the China-Brazil Traditional Chinese Medicine International Cooperation Base for Brazilian practitioners concluded successfully. This series of Traditional Chinese Medicine (TCM) training aimed to promote the popularization and application of TCM in Brazil and further strengthen the cooperation and exchange between the two countries in the field of TCM.
The series of training included three academic lectures, covering rich content such as TCM diagnostics and medication guidance. TCM experts from China provided comprehensive and in-depth TCM knowledge training to Brazilian practitioners through specialized lectures and interactive discussions.
During the training, Chinese experts detailed the basic theories and clinical applications of TCM and conducted case analyses and discussions. Participants actively engaged in interactions, posing many targeted questions and receiving detailed answers. Through this series of lectures, Brazilian practitioners not only deepened their understanding of TCM but also gained new insights into their prescription practices. Many practitioners expressed that they would apply the knowledge learned to their actual work to provide more comprehensive and effective medical services to their patients.
Tianjiang Pharmaceutical and the China-Brazil Traditional Chinese Medicine International Cooperation Base stated that they will continue to strengthen cooperation with Brazil in the field of TCM and continue to carry out academic exchange activities to promote the development of TCM in Brazil. The successful hosting of this event marks a solid step forward in the promotion of TCM in Brazil, deepening the cooperation between China and Brazil in the medical field and injecting new vitality into the international development of TCM.
Bortala Mongolian Autonomous Prefecture 220 kV Xinhua South Gathering Station successfully delivered electricity
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
Health In Tech Announces Closing of Initial Public Offering
Higer New V Series, Leading Bus New Trend
©copyright 2009-2020 Diet Tips Daily